IBT
INSM icon

International Biotechnology Trust’s Insmed INSM Stock Holding History

International Biotechnology Trust’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.01M Hold
40,100
– – 0.34% 51
2023
Q2 		$845K Hold
40,100
– – 0.26% 50
2023
Q1 		$682K Hold
40,100
– – 0.19% 56
2022
Q4 		$800K Hold
40,100
– – 0.25% 55
2022
Q3 		$864K Buy
40,100
+39,309
+4,970% +$942K 0.28% 54
2022
Q2 		$40.1K Sell
791
-39,309
-98% -$824K 0.42% 49
2022
Q1 		$14.3M Sell
40,100
-81,000
-67% -$1.88M 3.22% 11
2021
Q4 		$3.3M Sell
121,100
-120,000
-50% -$3.43M 0.74% 32
2021
Q3 		$6.64M Buy
241,100
+141,000
+141% +$3.7M 1.6% 22
2021
Q2 		$2.85M Buy
100,100
+66,500
+198% +$1.97M 0.75% 30
2021
Q1 		$1.14M Hold
33,600
– – 0.3% 45
2020
Q4 		$1.12M Hold
33,600
– – 0.31% 42
2020
Q3 		$1.08M Hold
33,600
– – 0.35% 42
2020
Q2 		$902K Hold
33,600
– – 0.3% 46
2020
Q1 		$537K Hold
33,600
– – 0.24% 50
2019
Q4 		$801K Sell
33,600
-323,000
-91% -$6.57M 0.29% 53
2019
Q3 		$6.29M Hold
356,600
– – 2.91% 13
2019
Q2 		$9.11M Buy
356,600
+246,600
+224% +$6.87M 3.38% 12
2019
Q1 		$3.2M Buy
+110,000
New +$2.85M 1.18% 28

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

International Biotechnology Trust's INSM Position: Q3 2023 in Review

International Biotechnology Trust held its Insmed (INSM) position steady in Q3 2023 at 40,100 shares worth $1.01M. The position accounts for 0.34% of the portfolio, ranked #51.

International Biotechnology Trust first reported a position in INSM in Q1 2019 and has held it in 19 quarters since. The position peaked at $14.3M in Q1 2022. 252 funds tracked by Wall St. Rank hold INSM as of Q3 2023.

  • International Biotechnology Trust held 40,100 shares of Insmed worth $1.01M as of Q3 2023.
  • International Biotechnology Trust left its Insmed share count unchanged in Q3 2023.
  • Insmed made up 0.34% of International Biotechnology Trust's portfolio in Q3 2023, its #51 holding.
  • International Biotechnology Trust first reported a position in Insmed in Q1 2019 and has held it in 19 quarters since.
  • International Biotechnology Trust's Insmed position peaked at $14.3M in Q1 2022.
  • 252 funds tracked by Wall St. Rank held Insmed as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.